Atossa Therapeutics Inc (NASDAQ: ATOS) on Friday, soared 9.78% from the previous trading day, before settling in for the closing price of $0.92. Within the past 52 weeks, ATOS’s price has moved between $0.55 and $1.66.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 36.92%. The company achieved an average annual earnings per share of -23.75%. With a float of $129.12 million, this company’s outstanding shares have now reached $129.17 million.
Atossa Therapeutics Inc (ATOS) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Atossa Therapeutics Inc is 0.04%, while institutional ownership is 20.93%. The most recent insider transaction that took place on May 21 ’25, was worth 9,887. In this transaction President & CEO of this company bought 11,239 shares at a rate of $0.88, taking the stock ownership to the 13,898 shares. Before that another transaction happened on Mar 26 ’25, when Company’s Director bought 10,000 for $0.70, making the entire transaction worth $7,000. This insider now owns 10,257 shares in total.
Atossa Therapeutics Inc (ATOS) Performance Highlights and Predictions
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.06 earnings per share (EPS) for the period topping the consensus outlook (set at -0.06) by 0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -23.75% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -15.73% during the next five years compared to 36.92% growth over the previous five years of trading.
Atossa Therapeutics Inc (NASDAQ: ATOS) Trading Performance Indicators
Atossa Therapeutics Inc (ATOS) is currently performing well based on its current performance indicators. A quick ratio of 9.17 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.22, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.28 in one year’s time.
Technical Analysis of Atossa Therapeutics Inc (ATOS)
The latest stats from [Atossa Therapeutics Inc, ATOS] show that its last 5-days average volume of 1.26 million was superior to 0.83 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 87.43%.
During the past 100 days, Atossa Therapeutics Inc’s (ATOS) raw stochastic average was set at 82.34%, which indicates a significant decrease from 83.55% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0455 in the past 14 days, which was lower than the 0.0465 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8140, while its 200-day Moving Average is $0.8227. Now, the first resistance to watch is $1.0660. This is followed by the second major resistance level at $1.1219. The third major resistance level sits at $1.1939. If the price goes on to break the first support level at $0.9381, it is likely to go to the next support level at $0.8661. Assuming the price breaks the second support level, the third support level stands at $0.8102.
Atossa Therapeutics Inc (NASDAQ: ATOS) Key Stats
Market capitalization of the company is 130.46 million based on 129,171K outstanding shares. Right now, sales total 0 K and income totals -25,500 K. The company made 0 K in profit during its latest quarter, and -8,420 K in sales during its previous quarter.
